Based on recent data, Phio Pharmaceuticals Corp. (PHIO) shows an Average True Range (ATR) of 0.15 and an Enterprise Value of -5.37M. Its average trading volume over the past 3 months is 3.95M, indicating liquidity. These fundamental metrics provide insight into PHIO's underlying financial health and market activity.
| ATR | 0.15 |
| Enterprise Value | -5.37M |
| Avg Vol (3 Months) | 3.95M |
| Avg Vol (10 Days) | 72.41K |
Phio Pharmaceuticals Corp. (PHIO) technical indicators as of May 2, 2026: the SMA 20 is -2.27%, SMA 50 at -2.31%, and SMA 200 at -41.06%. The RSI 14 value is 47.92, suggesting its current momentum. These technical analysis signals help assess PHIO's price trends and potential future movements.
| SMA 20 | -2.27% |
| SMA 50 | -2.31% |
| SMA 200 | -41.06% |
| RSI 14 | 47.92 |
Phio Pharmaceuticals Corp. (PHIO) stock performance overview as of May 2, 2026: The 52-week high is $4.19 (currently -74.46% below), and the 52-week low is $0.813 (currently 31.66% above). Over the past year, PHIO's performance is -62.89%, compared to the S&P 500's 17.86% change.
| 52-Week High | 4.19 |
| 52-Week High Chg | -74.46% |
| 52-Week Low | 0.8127 |
| 52-Week Low Chg | +31.66% |
| S&P 500 52-Week Chg | 17.86% |
According to market data, Phio Pharmaceuticals Corp. (PHIO) stock's recent performance metrics show that over the last month, PHIO is 0.93%, with a Year-to-Date (YTD) performance of 2.86%. Over the past year, the stock has seen a -62.89% change. These figures summarize PHIO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.26 | 1.35 | 1.88 | 4.19 | 4.19 | 1.88 |
| Low | 1.18 | 1.17 | 0.8127 | 0.8127 | 0.8127 | 0.8127 |
| Performance | -9.24% | +0.93% | -48.82% | -54.81% | -62.89% | +2.86% |
According to current financial data, PHIO stock's P/E (TTM) ratio is -1.62, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for PHIO, including P/S (N/A), P/B (0.70), and P/FCF (-1.76), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | PHIO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -1.62 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 0.7 | 0.97 | 1.01 | 4.72 |
| P/FCF (TTM) | -1.76 | -0.03 | -462.17 | 32.8 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep